Laboratory Corporation of America Holdings (LabCorp) represents a strong commitment to high-quality diagnostic services and leading advancements in healthcare. LabCorp values innovation, integrity, and collaboration, ensuring accurate and timely results for patients and healthcare providers worldwide. Their corporate philosophy emphasizes a patient-centric approach, focusing on bettering patient outcomes through advanced testing capabilities and personalized care. LabCorp's dedication to cutting-edge technology, scientific expertise, and ethical practices positions them as a trusted leader in the diagnostic industry. With a relentless pursuit of excellence, LabCorp strives to improve healthcare access and foster healthier communities through their comprehensive range of laboratory and diagnostic solutions.

Laboratory Corporation of America Holdings (LabCorp) primarily operates in the United States. With a network of over 2,000 patient service centers, LabCorp serves patients in all 50 states. As a leading global life sciences company, LabCorp also has international operations and serves clients in several countries worldwide. However, the company's core presence and operations are primarily focused on delivering comprehensive laboratory testing services within the United States.

Laboratory Corporation of America Holdings (LabCorp) has achieved several significant milestones in its history. One notable milestone was its founding in 1978, which established LabCorp as an independent clinical laboratory. Over the years, LabCorp has gained a reputation for providing high-quality and comprehensive diagnostic services, making it one of the leading providers in the healthcare industry. With continuous innovation and strategic acquisitions, LabCorp has expanded its capabilities, becoming a pioneer in advanced diagnostic testing, drug development services, and genomic testing. Furthermore, LabCorp's commitment to delivering accurate and timely results has earned the trust of healthcare professionals and patients alike, solidifying its position as a reliable and trusted leader in the industry.

Laboratory Corporation of America Holdings, commonly known as LabCorp, is a leading provider of individualized healthcare diagnostics and innovative testing services. Founded in 1978 and headquartered in Burlington, North Carolina, LabCorp has grown to become a global life sciences company. With a strong focus on scientific expertise and technological advancements, LabCorp offers a wide range of testing options across various medical specialties, including pathology, oncology, genetics, reproductive health, and clinical trials. LabCorp's commitment to high-quality and efficient diagnostics has bolstered its reputation as a trusted provider in the healthcare industry. Continuously striving to improve patient care and outcomes, LabCorp remains at the forefront of diagnostic innovation.

The main competitors of Laboratory Corporation of America Holdings in the market include Quest Diagnostics, Bio-Reference Laboratories, and Sonic Healthcare.

Laboratory Corporation of America Holdings (LabCorp) is primarily active in the healthcare industry, specifically in the life sciences and diagnostics sectors. As a leading global life sciences company, LabCorp offers a wide range of laboratory testing and diagnostic services. They serve various industries such as pharmaceuticals, biotechnology, hospitals, clinics, academic institutions, and contract research organizations. LabCorp plays a crucial role in supporting medical professionals, researchers, and patients by providing reliable and accurate testing solutions that contribute to the advancement of healthcare.

The business model of Laboratory Corporation of America Holdings primarily revolves around providing comprehensive laboratory testing services to healthcare providers, pharmaceutical companies, and individuals. As one of the largest clinical laboratory networks globally, Laboratory Corporation of America Holdings offers a wide range of testing services, including clinical research, cancer diagnostics, toxicology screenings, genetic testing, and general laboratory testing. Through their extensive network of laboratories and cutting-edge technologies, the company aims to deliver accurate and timely results to support healthcare diagnosis, treatment decisions, and drug development. Laboratory Corporation of America Holdings is committed to improving health outcomes by offering innovative laboratory solutions to its customers.

مُعامل القيمة السوقية إلى الأرباح لـ Laboratory Corporation of America Holdings هو ١٣٫٧٩.

مُعامِل القيمة إلى المبيعات Laboratory Corporation of America Holdings هو ١٫٣٤.

نقاط جودة AlleAktien لـ Laboratory Corporation of America Holdings هي 3/10.

المتوقعة Laboratory Corporation of America Holdings الإيرادات هي ١٣٫٢١ مليارات USD.

صافي الربح المتوقعة Laboratory Corporation of America Holdings هو ١٫٢٩ مليارات USD.

LabCorp is a leading company in the field of clinical diagnostics, providing medical diagnostic services to doctors, hospitals, and other healthcare facilities. It is divided into three main business segments: Diagnostics, Drug Development, and Technology Solutions. LabCorp offers a wide range of laboratory tests for different diseases and medical needs, conducts clinical studies for pharmaceutical and biotechnology companies, and provides IT solutions and support for medical facilities. It also has joint ventures and partnerships with other companies, including Covance, a leading provider of clinical development and laboratory services. LabCorp aims to improve healthcare through clinical diagnostics and innovative technology solutions. It has a strong market position, a diverse customer base, and generated a revenue of $14.9 billion in 2020.

يوزع Laboratory Corporation of America Holdings أرباحًا قدرها ٢٫١٦ USD من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Laboratory Corporation of America Holdings في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـLaboratory Corporation of America Holdings هو US50540R4092.

رمز WKN لـ Laboratory Corporation of America Holdings هو 895308.

الرمز المُختصر لـ Laboratory Corporation of America Holdings هو LH.

خلال آخر 12 شهراً، دفعت Laboratory Corporation of America Holdings توزيعات أرباح بقيمة ٢٫٨٨ USD . وهذا يعادل عائد توزيعات أرباح يقارب ١٫٤٢ %. ومن المتوقع أن تدفع Laboratory Corporation of America Holdings خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٣٫١٩ USD.

نسبة توزيعات الأرباح الحالية لـ Laboratory Corporation of America Holdings هي ١٫٤٢ %.

Laboratory Corporation of America Holdings يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر ديسمبر, مارس, يونيو, يونيو.

Laboratory Corporation of America Holdings دفعت توزيعات الأرباح كل عام خلال الـ7 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٣٫١٩ USD. وهذا يعادل عائد توزيعات أرباح قدره ١٫٥٦ %.

Laboratory Corporation of America Holdings يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٠٫٧٢ USD من Laboratory Corporation of America Holdings المُعلن عنها في ١٢‏/٦‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٨‏/٥‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ١٢‏/٦‏/٢٠٢٤.

في العام 2023، وزعت Laboratory Corporation of America Holdings ٢٫١٦ USD كأرباح أسهم.

يتم توزيع أرباح Laboratory Corporation of America Holdings بالعملة USD.